In a separate RCT assessing diabetic neuropathy in patients with type 1 diabetes (T1DM), liraglutide was not shown to alter neuronal function; however, inflammatory cytokines like IL‐6 were reduced, which may modulate the neuroinflammatory component of peripheral neuropathy [64]. Here, IL6 is linked to type 1 diabetes mellitus.